In this third episode, Michael addresses the concept of quality of life and how ones choice of treatment impacts the future. He profiles his own challenges with post-operative side effects including

In this second episode, Michael presents the basics of decision making as it pertains to critical choices he faced, including selecting the type of prostate biopsy. He explains what is communicated in

In this first episode, Michael introduces us to his personal journey with prostate cancer. It begins with addressing PSA and the role of this tumor marker in risk assessment for prostate cancer. He di

Mark the 2022 Prostate Cancer Awareness Month with Dr. Michael Lutz, president of the MIU Mens Health Foundation, and prostate cancer survivor and former Navy pilot, Craig Reiner, as they discuss the

Thanks to MPCC board members Allen Snyder and Analesa Baraka who join MPCC Medical Advisory Committee member Dr. Quoc -Dien Trinh in discussing Shared Decision Making: Then and Now. This podcast inc

Join Dr. Adam Kibel, Clare Tempany, J. Jacques Carter, Richard Babayan, and Glenn Bubley as they reflect on the advances in prostate cancer diagnosis, treatment and research since the Jack Colbert Mem

Thanks to David Einstein, MD, from Beth Israel Deaconess Medical Center, for discussing Into the Unknown: How Do We Study Prostate Cancer Treatments, For every exciting new therapy, there is a long

Thanks to Christina Dieli-Conwright, PhD, MPH,Dana-Farber Cancer Institute for discussing Exercise as Medicine for Prostate Cancer Survivorship. Persons at risk and diagnosed with prostate cancer a

Thanks to Adam Feldman, MD, PH, for discussing Prostate Cancer Detection: Past, Present and Future. Dr. Feldman is a urologic oncologist at the Massachusetts General Hospital Department of Urology.

Thanks to Dr. Marianne Brandon, clinical psychologist and diplomat in sex therapy, for this interview on Sex and Intimacy after Prostate Cancer, in which she discusses this topic in the broader con